Time in tight glucose range in adolescents and young adults with diabetes during Ramadan intermittent fasting: Data from real-world users on different treatment strategies

IF 7.4 3区 医学 Q1 ENDOCRINOLOGY & METABOLISM Diabetes research and clinical practice Pub Date : 2025-03-01 Epub Date: 2025-02-16 DOI:10.1016/j.diabres.2025.112042
Nancy Samir Elbarbary , Eman Abdel Rahman Ismail
{"title":"Time in tight glucose range in adolescents and young adults with diabetes during Ramadan intermittent fasting: Data from real-world users on different treatment strategies","authors":"Nancy Samir Elbarbary ,&nbsp;Eman Abdel Rahman Ismail","doi":"10.1016/j.diabres.2025.112042","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Time in tight range (TITR) is a novel glycemic metric assessing normoglycemia in individuals with diabetes.</div></div><div><h3>Aim</h3><div>To assess the attainability of the TITR (70–140 mg/dL) target in youth with diabetes using different treatment strategies during Ramadan fasting.</div></div><div><h3>Methods</h3><div>This prospective study included 276 non-insulin-treated type 2 diabetes mellitus (T2DM) and 426 patients with type 1 diabetes mellitus (T1DM) who were categorized into: multiple daily injections [MDI] + intermittently scanned CGM (isCGM), sensor augmented pump (SAP) and advanced hybrid closed loop (AHCL).</div></div><div><h3>Results</h3><div>At the end of Ramadan, the mean TITR was 42.3 ± 6.6 % for all T1DM patients and 63.5 ± 4.0 % in T2DM (p &lt; 0.001). The highest TITR was in T2DM group together with T1DM on AHCL (62.3 ± 11.6 %), followed by SAP group (37.7 ± 5.7 %) and MDI + isCGM group (23.6 ± 5.9 %, p &lt; 0.001). Hypoglycemic episodes as shown by time below range (TBR) &lt; 70 mg/dL and TBR &lt; 54 mg/dL were minimal during Ramadan in AHCL group in comparison to before Ramadan (2.6 ± 0.7 versus 2.9 ± 0.9 %; p = 0.061 and 0.4 ± 0.1 vs 0.5 ± 0.1 %, p = 0.561, respectively) with a lower coefficient of variation (CoV) (p &lt; 0.001) than other T1DM participants.</div></div><div><h3>Conclusion</h3><div>At the end of Ramadan, TITR was decreased in patients with T1DM except those using AHCL who had similar levels to non-insulin-treated T2DM patients. Advanced technology has the potential for achieving tight glycemic targets, along with a reduction in CoV, without increasing hypoglycemic risk compared with other insulin treatment modalities.</div></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":"221 ","pages":"Article 112042"},"PeriodicalIF":7.4000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822725000567","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Time in tight range (TITR) is a novel glycemic metric assessing normoglycemia in individuals with diabetes.

Aim

To assess the attainability of the TITR (70–140 mg/dL) target in youth with diabetes using different treatment strategies during Ramadan fasting.

Methods

This prospective study included 276 non-insulin-treated type 2 diabetes mellitus (T2DM) and 426 patients with type 1 diabetes mellitus (T1DM) who were categorized into: multiple daily injections [MDI] + intermittently scanned CGM (isCGM), sensor augmented pump (SAP) and advanced hybrid closed loop (AHCL).

Results

At the end of Ramadan, the mean TITR was 42.3 ± 6.6 % for all T1DM patients and 63.5 ± 4.0 % in T2DM (p < 0.001). The highest TITR was in T2DM group together with T1DM on AHCL (62.3 ± 11.6 %), followed by SAP group (37.7 ± 5.7 %) and MDI + isCGM group (23.6 ± 5.9 %, p < 0.001). Hypoglycemic episodes as shown by time below range (TBR) < 70 mg/dL and TBR < 54 mg/dL were minimal during Ramadan in AHCL group in comparison to before Ramadan (2.6 ± 0.7 versus 2.9 ± 0.9 %; p = 0.061 and 0.4 ± 0.1 vs 0.5 ± 0.1 %, p = 0.561, respectively) with a lower coefficient of variation (CoV) (p < 0.001) than other T1DM participants.

Conclusion

At the end of Ramadan, TITR was decreased in patients with T1DM except those using AHCL who had similar levels to non-insulin-treated T2DM patients. Advanced technology has the potential for achieving tight glycemic targets, along with a reduction in CoV, without increasing hypoglycemic risk compared with other insulin treatment modalities.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
青少年和年轻糖尿病患者在斋月间歇禁食期间血糖处于较紧范围的时间:来自不同治疗策略的现实世界用户的数据
背景:窄范围时间(TITR)是一种评估糖尿病患者血糖正常的新型血糖指标。目的评估斋月期间不同治疗策略对青年糖尿病患者TITR (70-140 mg/dL)目标的可达性。方法前瞻性研究纳入276例未胰岛素治疗的2型糖尿病(T2DM)患者和426例合并1型糖尿病(T1DM)患者,分为:每日多次注射(MDI) +间歇扫描CGM (isCGM)、传感器增强泵(SAP)和晚期混合闭环(AHCL)。结果斋月结束时,T1DM患者的平均TITR为42.3±6.6%,T2DM患者的平均TITR为63.5±4.0% (p <;0.001)。T2DM合并T1DM患者AHCL的TITR最高(62.3±11.6%),SAP组次之(37.7±5.7%),MDI + isCGM组次之(23.6±5.9%),p <;0.001)。低血糖发作(TBR) <;70 mg/dL和TBR <;与斋月前相比,AHCL组在斋月期间最低为54 mg/dL(2.6±0.7 vs 2.9±0.9%);p = 0.061和0.4±0.1 vs 0.5±0.1%,p = 0.561),变异系数(CoV)较低(p <;0.001),高于其他T1DM参与者。结论斋月结束时,除了AHCL患者的TITR水平与未胰岛素治疗的T2DM患者相似外,T1DM患者的TITR水平均有所下降。与其他胰岛素治疗方式相比,先进技术有可能实现严格的血糖目标,同时减少冠状病毒,而不会增加低血糖风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Diabetes research and clinical practice
Diabetes research and clinical practice 医学-内分泌学与代谢
CiteScore
10.30
自引率
3.90%
发文量
862
审稿时长
32 days
期刊介绍: Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.
期刊最新文献
Target trial emulations for tirzepatide, semaglutide and SGLT2-inhibitors for dementia in patients with type 2 diabetes: Real world evidence from a retrospective cohort study Precision staging of Type 2 diabetes through Hypergraph-Based multimorbidity Profiling: From hepatic disruption to cardiovascular escalation High-normal levels of B-type natriuretic peptide are associated with chronic kidney disease progression independent of albuminuria in individuals with diabetes: an observational cohort study Impact of metformin on the risk of osteoarthritis in patients with type 2 diabetes: a real-world study The impact of COVID-19 illness on metabolic phenotypes underlying type 2 diabetes mellitus: a systematic review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1